A word from the CEO: 2014 in review

2014 was an amazing year at Cortechs.ai. We experienced remarkable growth in all aspects of the company and added many significant hospitals, clinics, universities, imaging service facilities and military bases as customers. I want to warmly thank you for using NeuroQuant in your clinical and research practices.

In my role as the CEO of Cortechs.ai, I get many opportunities to speak with a range of customers – from the neurology and neuroradiology heads of the largest hospitals and clinics, to the smallest imaging services facilities, in the US and in Europe. It is always a great opportunity for me to get a first-hand impression of the state-of-the-art trends in radiology and neurology and to sense the reality and daily challenges of providing imaging healthcare services.

What I have learned this year is that quantitative imaging is getting acceptance in clinical practice and that measuring sub-cortical brain volumes and comparing them to normative values has clinical application in a growing number of clinical disciplines, from dementia, through epilepsy, multiple sclerosis, traumatic brain injuries and a variety of pediatric disorders.

Armed with great customer feedback and with growth momentum, we are getting ready to improve NeuroQuant even further to keep its leading position in the T1-weighted quantitative imaging market. This year NeuroQuant customer will enjoy a much broader set of reports highlighting more brain volumes that are relevant to the above clinical disciplines.  Additionally, we will further improve scan/re-scan accuracy, computational performance and the support of additional platforms such as Windows and Linux.

As usual, we always look for feedback and ideas for improvement and we welcome anybody that wants to share it with us.

I would like to invite you to our website (cortechs.ai) where you will find a wealth of information and scientific publications relevant to quantitative imaging.

Whether you are looking to learn and educate yourself about quantitative neuroimaging, or if you want to hear how to use it in clinical practice – we can help. Feel free to contact us.

Guri Stark
CEO
Cortechs.ai

More Resources

03/20/2025

Cortechs.ai Announces Strategic Distribution Partnership with Medical Horizons to Expand Presence in Italy, Turkey, and the Middle East

We are pleased to announce a strategic distribution partnership with Medical Horizons, a premier AI-powered medical device distributor based in Florence, Italy.

03/18/2025

Unlocking the Power of AI Imaging in Multiple Sclerosis: How NeuroQuant® MS Enhances Lesion Detection and Monitoring

Unlock the power of AI-driven imaging with NeuroQuant® MS—enhancing lesion detection, monitoring, and personalized care for Multiple Sclerosis.

03/09/2025

Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health

AI-driven MRI with NeuroQuant® enhances TBI assessment, tracks recovery, and supports better treatment decisions.

03/06/2025

Case Study: Leveraging NeuroQuant® for Accurate Diagnosis of Traumatic Brain Injury

This case highlights the power of advanced neuroimaging tools in delivering precise, evidence-based diagnostics to enhance patient care and clinical decisions.

02/26/2025

Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

NeuroQuant enables objective brain volume tracking for early TBI detection, recovery monitoring, and safer return-to-play decisions.

02/25/2025

OnQ™ Prostate Solution Enhances Collaboration and Improves MRI for Cancer Detection with RSI Technology

OnQ Prostate enhances MRI tissue characterization, improving sensitivity and specificity in cancer detection, & bridges gaps between radiologists and urologists
Scroll to Top